Progyny to Discuss Updated Financial Expectations at Upcoming JP Morgan Healthcare Conference

Anticipates Fourth Quarter and Full Year Results to be Slightly Above Previously Provided Financial GuidanceNEW YORK, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY) (“Progyny” or the “Company”), a transformative fertility, family building and women’s health benefits solution, today announced that the Company is participating in the 43rd Annual JP Morgan Healthcare Conference, where it intends to discuss its updated expectations for the quarter and year ending December 31, 2024. In its Novemb ...